2004-03-01
Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry).
Publication
Publication
The American Journal of Cardiology , Volume 93 - Issue 5 p. 633- 636
A total of 91 patients with 112 lesions received 2.25-mm sirolimus-eluting stents (SESs), and these lesions were compared with those treated with SESs of ≥2.5-mm diameter in the same procedure (n = 109). The reference diameters were 1.88 ± 0.34 and 2.52 ± 0.57 mm, respectively (p <0.01). At follow-up, the late lumen loss was 0.07 ± 0.48 mm for the 2.25-mm SES versus 0.03 ± 0.38 mm for the larger SES (p = 0.5), and the binary restenosis rate was 10.7% versus 3.9%, respectively (p = 0.1). The 12-month target lesion revascularization rate was 5.5%. In conclusion, 2.25-mm SESs were associated with low rates of clinical and angiographic late complications.
| Additional Metadata | |
|---|---|
| , , | |
| doi.org/10.1016/j.amjcard.2003.11.037, hdl.handle.net/1765/4672 | |
| The American Journal of Cardiology | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Lemos Neto, P., Arampatzis, C., Saia, F., Hoye, A., Degertekin, M., Tanabe, K., Lee, C. H., Cummins, P., Smits, P., McFadden, E., Sianos, G., van der Giessen, W., van Domburg, R., Serruys, P.& de Feyter, P. (2004). Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH registry). The American Journal of Cardiology, 93(5), 633–636.https://doi.org/10.1016/j.amjcard.2003.11.037 |
|